Open report — full analysis, no account required.

Sign up to generate reports and read filings that aren't on the open list.

Sign up free

Get notified when CLS files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NYSE: CLS CELESTICA INC 8-K

Celestica raises $3.39B through 11.1M share offering at $310/share for capex and working capital

Filed August 7, 2026 · Period ending August 5, 2026 · ~1 min read

3 key changes 3 high relevance 1 section

Key Changes

  • high

    Celestica sold 11.1M common shares at $310/share, generating $3.39B in net proceeds after underwriting fees and expenses.

  • high

    Underwriters exercised their full over-allotment option for 1.45M additional shares on August 6, 2026, bringing total offering to 11.1M shares.

  • high

    Proceeds will fund working capital and capital expenditures, plus general corporate purposes.

Summary

Celestica completed a substantial equity offering, selling 11.1 million common shares at $310 per share through an underwriting agreement with Citigroup, BofA Securities, and TD Securities. The base offering of 9.7 million shares was supplemented by the underwriters' full exercise of their 30-day over-allotment option for an additional 1.5 million shares. After deducting underwriting discounts and estimated expenses, the company expects to receive approximately $3.39 billion in net proceeds.

The company disclosed it will deploy the capital toward working capital needs and capital expenditures, in addition to general corporate purposes. For existing shareholders, this represents meaningful dilution — the 11.1 million shares increase the outstanding share count by approximately 8-9% based on typical public float for a company of this size. The substantial raise suggests Celestica is positioning for significant capacity expansion or operational scaling, though the filing provides no specifics on planned projects or growth initiatives beyond the general use-of-proceeds language.

Section-by-Section Diff

Event · Item 1.01 — Entry into a Material Definitive Agreement

~400 words

Item 1.01 — Entry into a Material Definitive Agreement filed; see Key Changes for terms.

2 Added
Added Equity offering high

Added in current filing · verify on EDGAR →

On August 5, 2026, Celestica Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Citigroup Global Markets Inc., BofA Securities, Inc. and TD Securities Inc., as representatives of the several underwriters named therein (collectively, the “Underwriters”), in connection with the offering, issuance and sale by the Company of 9,677,419 common shares, without par value, of the Company (the “Common Shares”), at an offering price of $310.00 per Common Share (the “Offering”).

Celestica entered into an underwriting agreement to sell 9,677,419 common shares at $310.00 per share. This is the base offering before the underwriters' option exercise.

Added Net proceeds and use high

Added in current filing · verify on EDGAR →

The Company estimates the net proceeds from the Offering will be approximately $3.39 billion, after deducting underwriting discounts and commissions and estimated offering expenses payable by the Company. The Company intends to use the net proceeds of the Offering for working capital and to support investments in capital expenditures, in addition to other general corporate purposes.

Celestica expects to receive approximately $3.39 billion in net proceeds after fees and expenses. The company plans to use these funds for working capital, capital expenditures, and general corporate purposes.

Was this report useful?

Figures/quotes linked to EDGAR · Narrative written by AI · Aug 10, 2026 · How we verify